MedicaidPrior AuthLow impact
Atypical Antipsychotics Added to the MD Preferred Drug List
Maryland Medicaid·MD · Psychiatry, Pharmacy·Pharmacy
Effective date
Jan 1, 2008
We identified it
Jun 20, 2026
Summary
Maryland Medicaid is adding atypical antipsychotic drugs to their Preferred Drug List effective January 1, 2008, with most requiring no prior authorization except Zyprexa which requires step therapy. Additionally, antiretroviral drugs are being carved out to fee-for-service billing with new co-payment requirements.
Action Required
This is a historical policy from 2008 that is no longer relevant for current billing operations. No action required as this policy has been superseded by newer guidance over the past 16+ years.